# FDA 483 - Lawrence W. Johnson, M.D. - October 13, 2023

Source: https://www.keypedia.com/records/483/lawrence-w-johnson-md/4895af93-e93c-4b4b-9f50-4bce40a5d5af

> FDA 483 for Lawrence W. Johnson, M.D. on October 13, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lawrence W. Johnson, M.D.
- Inspection Date: 2023-10-13
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: The FDA issued a Form 483 to Louisiana Research Center Llc. in Shreveport, LA, following an inspection that revealed significant deficiencies in the conduct of a clinical investigation. The firm failed to properly supervise the study, ensure subjects met eligibility criteria, and obtain informed consent from four out of eleven randomized subjects. These findings indicate serious non-compliance with regulatory requirements for human subject protection and clinical trial conduct.

## Related Officers

- [Christopher M. Jeffers](https://www.keypedia.com/people/christopher-m-jeffers/327faaff-619a-4180-ab4c-b5f1b5ba84be)
- [investigator](https://www.keypedia.com/people/kellie-r-riggs/556818c6-eb9a-48a5-9630-aba7a807ec07)

Company: https://www.keypedia.com/companies/lawrence-w-johnson-md/caa7a30d-5f1b-4caf-986d-307dffb168dc

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea